Predictive Value of Diffusion, Glucose Metabolism Parameters of PET/MR in Patients With Head and Neck Squamous Cell Carcinoma Treated With Chemoradiotherapy-Reference-Cited by-同舟云学术

Predictive Value of Diffusion, Glucose Metabolism Parameters of PET/MR in Patients With Head and Neck Squamous Cell Carcinoma Treated With Chemoradiotherapy

Published:2020-09-02 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Kedves András,Tóth Zoltán,Emri Miklós,Fábián Krisztián,Sipos Dávid,Freihat Omar,Tollár József,Cselik Zsolt,Lakosi Ferenc,Bajzik Gábor,Repa Imre,Kovács Árpád

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference37 articles.

1. Head and neck cancer;Argiris;Lancet.,2008

2. 18F-FDG PET/CT is an early predictor of pathologic tumor response and survival after preoperative radiochemotherapy with bevacizumab in high-risk locally advanced rectal cancer;Avallone;J Nucl Med,2019

3. Tumor subregion evolution-based imaging features to assess early response and predict prognosis in oropharyngeal cancer;Wu;J Nucl Med.,2019

4. CT evaluation of squamous cell carcinoma of the nasopharynx;Raica;Curr Health Sci J.,2019

5. PET/MR in cancers of the head and neck;Queiroz;Semin Nucl Med.,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Applications of PET/MR: Part I: Technical Basics and Preclinical/Clinical Applications;Canadian Association of Radiologists Journal;2024-05-30

2. Prospective Investigation of 18FDG-PET/MRI with Intravoxel Incoherent Motion Diffusion-Weighted Imaging to Assess Survival in Patients with Oropharyngeal or Hypopharyngeal Carcinoma;Cancers;2022-12-12

3. Correlation between Tissue Cellularity and Metabolism Represented by Diffusion-Weighted Imaging (DWI) and 18F-FDG PET/MRI in Head and Neck Cancer (HNC);Cancers;2022-02-08

4. Pre-treatment PET/MRI based FDG and DWI imaging parameters for predicting HPV status and tumor response to chemoradiotherapy in primary oropharyngeal squamous cell carcinoma (OPSCC);Oral Oncology;2021-05